Cargando…
Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) contributes to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. During NAFLD pathogenesis, hepatic parenchymal cells (hepatocytes) undergo...
Autores principales: | Guo, Yan, Miao, Xiulian, Sun, Xinyue, Li, Luyang, Zhou, Anqi, Zhu, Xi, Xu, Yong, Wang, Qinghua, Li, Zilong, Fan, Zhiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206499/ https://www.ncbi.nlm.nih.gov/pubmed/37234276 http://dx.doi.org/10.1016/j.jhepr.2023.100724 |
Ejemplares similares
-
C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
por: Fan, Zhiwen, et al.
Publicado: (2023) -
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking
por: Li, Nan, et al.
Publicado: (2023) -
TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response
por: Sun, Xinyue, et al.
Publicado: (2023) -
Adaptive Evolution in Zinc Finger Transcription Factors
por: Emerson, Ryan O., et al.
Publicado: (2009) -
Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT Locus
por: Wilson, Kimberly A, et al.
Publicado: (2013)